JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delaria, K. A.
Right arrow Articles by Tamburini, P. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delaria, K. A.
Right arrow Articles by Tamburini, P. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


Volume 272, Number 18, Issue of May 2, 1997 pp. 12209-12214
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Characterization of Placental Bikunin, a Novel Human Serine Protease Inhibitor

(Received for publication, December 11, 1996)

Katherine A. Delaria Dagger , Daniel K. Muller § , Christopher W. Marlor § , James E. Brown , Rathindra C. Das Dagger , Steven O. Roczniak Dagger and Paul P. Tamburini par

From Dagger  Preclinical Research, Biotechnology Unit, § Institute for Bone and Joint Disease and Cancer, and par  Institute for Research Technologies, Pharmaceuticals Division, Bayer Corporation, West Haven, Connecticut 06516 and  Process Science, Biotechnology Unit, Berkeley, California 94710

We reported previously the cloning of a novel human serine protease inhibitor containing two Kunitz-like domains, designated as placental bikunin, and the subsequent purification of a natural counterpart from human placental tissue (Marlor, C. W., Delaria, K. A., Davis, G., Muller, D. K., Greve, J. M., and Tamburini, P. P. (1997) J. Biol. Chem. 272, 12202-12208). In this report, the 170 residue extracellular domain of placental bikunin (placental bikunin(1-170)) was expressed in baculovirus-infected Sf9 cells using its putative signal peptide. The resulting 21.3-kDa protein accumulated in the medium with the signal peptide removed and could be highly purified by sequential kallikrein-Sepharose and C18 reverse-phase chromatography. To provide insights as to the potential in vivo functions of this protein, we performed an extensive investigation of the inhibitory properties of recombinant placental bikunin(1-170) and both of its synthetically prepared Kunitz domains. All three proteins inhibited a number of serine proteases involved in the intrinsic pathway of blood coagulation and fibrinolysis. Placental bikunin(1-170) formed inhibitor-protease complexes with a 1:2 stoichiometry and strongly inhibited human plasmin (Ki = 0.1 nM), human tissue kallikrein (Ki = 0.1 nM), human plasma kallikrein (Ki = 0.3 nM) and human factor XIa (Ki = 6 nM). Conversely, this protein was a weaker inhibitor of factor VIIa-tissue factor (Ki = 1.6 µM), factor IXa (Ki = 206 nM), factor Xa (Ki = 364 nM), and factor XIIa (Ki = 430 nM). This specificity profile was to a large extent mimicked, albeit with reduced potency, by the individual Kunitz domains. As predicted from this in vitro specificity profile, recombinant placental bikunin(1-170) prolonged the clotting time in an activated partial thromboplastin time assay.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Szabo, J. P. Hobson, K. List, A. Molinolo, C.-Y. Lin, and T. H. Bugge
Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity
J. Biol. Chem., October 24, 2008; 283(43): 29495 - 29504.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
K. Nakamura, F. Abarzua, A. Hongo, J. Kodama, Y. Nasu, H. Kumon, and Y. Hiramatsu
Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer
Ann. Onc., August 9, 2008; (2008) mdn556v1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Moran, W. Li, B. Fan, R. Vij, C. Eigenbrot, and D. Kirchhofer
Pro-urokinase-type Plasminogen Activator Is a Substrate for Hepsin
J. Biol. Chem., October 13, 2006; 281(41): 30439 - 30446.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Odet, A. Verot, and B. Le Magueresse-Battistoni
The Mouse Testis Is the Source of Various Serine Proteases and Serine Proteinase Inhibitors (SERPINs): Serine Proteases and SERPINs Identified in Leydig Cells Are under Gonadotropin Regulation
Endocrinology, September 1, 2006; 147(9): 4374 - 4383.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. R. Morris, D. Gentle, M. Abdulrahman, E. N. Maina, K. Gupta, R. E. Banks, M. S. Wiesener, T. Kishida, M. Yao, B. Teh, et al.
Tumor Suppressor Activity and Epigenetic Inactivation of Hepatocyte Growth Factor Activator Inhibitor Type 2/SPINT2 in Papillary and Clear Cell Renal Cell Carcinoma
Cancer Res., June 1, 2005; 65(11): 4598 - 4606.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. A. Caldwell, R. C. Boucher, and M. J. Stutts
Neutrophil elastase activates near-silent epithelial Na+ channels and increases airway epithelial Na+ transport
Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L813 - L819.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Tian, E. Huitema, L. da Cunha, T. Torto-Alalibo, and S. Kamoun
A Kazal-like Extracellular Serine Protease Inhibitor from Phytophthora infestans Targets the Tomato Pathogenesis-related Protease P69B
J. Biol. Chem., June 18, 2004; 279(25): 26370 - 26377.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. A. Borgono, I. P. Michael, and E. P. Diamandis
Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer
Mol. Cancer Res., May 1, 2004; 2(5): 257 - 280.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Fukai, O. Yokosuka, T. Chiba, Y. Hirasawa, M. Tada, F. Imazeki, H. Kataoka, and H. Saisho
Hepatocyte Growth Factor Activator Inhibitor 2/Placental Bikunin (HAI-2/PB) Gene Is Frequently Hypermethylated in Human Hepatocellular Carcinoma
Cancer Res., December 15, 2003; 63(24): 8674 - 8679.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Kirchhofer, M. Peek, W. Li, J. Stamos, C. Eigenbrot, S. Kadkhodayan, J. M. Elliott, R. T. Corpuz, R. A. Lazarus, and P. Moran
Tissue Expression, Protease Specificity, and Kunitz Domain Functions of Hepatocyte Growth Factor Activator Inhibitor-1B (HAI-1B), a New Splice Variant of HAI-1
J. Biol. Chem., September 19, 2003; 278(38): 36341 - 36349.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. J. Bridges, B. B. Newton, J. M. Pilewski, D. C. Devor, C. T. Poll, and R. L. Hall
Na+ transport in normal and CF human bronchial epithelial cells is inhibited by BAY 39-9437
Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L16 - L23.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Itoh, H. Kataoka, M. Tomita, R. Hamasuna, Y. Nawa, N. Kitamura, and M. Koono
Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa
Am J Physiol Gastrointest Liver Physiol, April 1, 2000; 278(4): G635 - G643.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. J. Thomas, S. Yung, and M. Davies
Bikunin Present in Human Peritoneal Fluid Is in Part Derived from the Interaction of Serum with Peritoneal Mesothelial Cells
Am. J. Pathol., October 1, 1998; 153(4): 1267 - 1276.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Milstone, L. M. Harrison, R. D. Bungiro, P. Kuzmic, and M. Cappello
A Broad Spectrum Kunitz Type Serine Protease Inhibitor Secreted by the Hookworm Ancylostoma ceylanicum
J. Biol. Chem., September 15, 2000; 275(38): 29391 - 29399.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kataoka, T. Shimomura, T. Kawaguchi, R. Hamasuna, H. Itoh, N. Kitamura, K. Miyazawa, and M. Koono
Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Specific Cell Surface Binding Protein of Hepatocyte Growth Factor Activator (HGFA) and Regulates HGFA Activity in the Pericellular Microenvironment
J. Biol. Chem., December 15, 2000; 275(51): 40453 - 40462.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. van Adelsberg, S. Sehgal, A. Kukes, C. Brady, J. Barasch, J. Yang, and Y. Huan
Activation of Hepatocyte Growth Factor (HGF) by Endogenous HGF Activator Is Required for Metanephric Kidney Morphogenesis in Vitro
J. Biol. Chem., April 27, 2001; 276(18): 15099 - 15106.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.